Differentiating diastolic dysfunction from classic heart failure

Heart and Metabolism

Volumn , Issue 57, 2012, Pages 4-7

  Jaswal, Jagdip S ^a   Ussher, John R ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Cardiac energetics; Diabetic cardiomyopathy; Diastolic dysfunction; Heart failure; Obesity

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIASTOLIC HEART FAILURE; ENERGY METABOLISM; HEART EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; MUSCLE ISCHEMIA; OBESITY; PHENOTYPE; PRIORITY JOURNAL; SYSTOLIC HEART FAILURE;

EID: 84874499349     PISSN: 15660338     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hunt SA, Baker DW, Chin MH, et al (2006) ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration with the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America Circulation 104:2996-3007
2. Bhatia RS, Tu JV, Lee DS, et al (2006) Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355:260-269
3. Wood P, Piran S, Liu PP (2011) Diastolic heart failure: progress, treatment challenges, and preventio. Can J Cardiol 27:302-310
4. Lee DS, Gona P, Vasan RS, et al (2009) Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation 119:3070-3077
5. Regan TJ, Lyons MM, Ahmed SS, et al (1977) Evidence for cardiomyopathy in familial diabetes mellitus J Clin Invest 60:884-899
6. Devereux RB, Roman MJ, Paranicas M, et al (2000) Impact of diabetes on cardiac structure and function: the strong heart study Circulation 101:2271-2276
7. Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham study Am J Cardiol 34:29-34
8. Gaasch WH, Zile MR (2011) Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry J Am Coll Cardiol 58:1733-1740
9. Zile MR, Brutsaert DL (2002) New concepts in diastolic dysfunction and diastolic heart failure. Part II: Causal mechanisms and treatment Circulation 105:1503-1508
10. Zile MR, Brutsaert DL (2002) New concepts in diastolic dysfunction and diastolic heart failure. Part I: Diagnosis, prognosis, and measurements of diastolic function Circulation 105:1387-1393
11. Zile MR, Gottdiener JS, Hetzel SJ, et al I-PRESERVE Investigators (2011) Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction Circulation 124:2491-2501
12. Smiseth OA, Thompson CR (2000) Atrioventricular filling dynamics, diastolic function and dysfunction Heart Fail Rev 5:291-299
13. Ingwall JS (2009) Energy metabolism in heart failure and remodelling Cardiovasc Res 81:412-419
14. Neubauer S, Krahe T, Schindler R, et al (1992) 31P Magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure Circulation 86:1810-1818
15. Smith CS, Bottomley PA, Schulman SP, Gerstenblith G, Weiss RG (2006) Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium Circulation 114:1151-1158
16. Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD (2011) Targeting fatty acid and carbohydrate oxidation - a novel therapeutic intervention in the ischemic and failing heart Biochim Biophys Acta 1813:1333-1350
17. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC (2010) Myocardial fatty acid metabolism in health and disease Physiol Rev 90:207-258
18. Basu R, Oudit GY, Wang X, et al (2009) Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function. Am J Physiol Heart Circ Physiol 297:H2096-2108
19. Rijzewijk LJ, van der Meer RW, Lamb HJ, et al (2009) Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging J Am Coll Cardiol 54:1524-1532
20. Zhang L, Lu Y, Jiang H, Sun A, Zou Y, Ge J (2012) Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis J Am Coll Cardiol 59:913-922